Literature DB >> 18163226

Emerging treatment of atopic dermatitis.

Chih-Jung Hsu1, Li-Fang Wang.   

Abstract

Atopic dermatitis is a chronically relapsing eczematous disease of the skin. A wide range of therapeutic regimens has been used for atopic dermatitis. A better understanding of its pathogenesis will also lead to the development of novel approaches to treating this disease. This article reviews the recent advances in allergen-specific sublingual immunotherapy and therapy with antileukotriene drugs, probiotics, mycophenolate mofetil, leflunomide, and intermittent fluticasone propionate ointment, which the authors expect will be clinically useful therapies in the near future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163226     DOI: 10.1007/s12016-007-0043-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  54 in total

Review 1.  Pathophysiology of atopic dermatitis.

Authors:  Kefei Kang; Seth R Stevens
Journal:  Clin Dermatol       Date:  2003 Mar-Apr       Impact factor: 3.541

Review 2.  Noninjection routes for immunotherapy.

Authors:  Giorgio Walter Canonica; Giovanni Passalacqua
Journal:  J Allergy Clin Immunol       Date:  2003-03       Impact factor: 10.793

3.  The intestinal microflora in allergic Estonian and Swedish 2-year-old children.

Authors:  B Björkstén; P Naaber; E Sepp; M Mikelsaar
Journal:  Clin Exp Allergy       Date:  1999-03       Impact factor: 5.018

Review 4.  Treatment of asthma with drugs modifying the leukotriene pathway.

Authors:  J M Drazen; E Israel; P M O'Byrne
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

5.  Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.

Authors:  F Mastrandrea; G Serio; M Minelli; A Minardi; G Scarcia; G Coradduzza; S Parmiani
Journal:  Allergol Immunopathol (Madr)       Date:  2000 Mar-Apr       Impact factor: 1.667

6.  The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.

Authors:  D J Yanase; K David-Bajar
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

7.  Probiotics in the management of atopic eczema.

Authors:  E Isolauri; T Arvola; Y Sütas; E Moilanen; S Salminen
Journal:  Clin Exp Allergy       Date:  2000-11       Impact factor: 5.018

8.  Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.

Authors:  K L E Hon; T F Leung; K C Ma; Y Wong; T F Fok
Journal:  J Dermatolog Treat       Date:  2005-02       Impact factor: 3.359

9.  Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

Authors:  Marko Kalliomäki; Seppo Salminen; Tuija Poussa; Heikki Arvilommi; Erika Isolauri
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

10.  Acute and maintenance treatment of atopic dermatitis in children - two comparative studies with fluticasone propionate (0.05%) cream.

Authors:  M E Kirkup; N M Birchall; E G Weinberg; K Helm; C T C Kennedy
Journal:  J Dermatolog Treat       Date:  2003-09       Impact factor: 3.359

View more
  6 in total

1.  The role of airborne proteins in atopic dermatitis.

Authors:  Sarah Grim Hostetler; Benjamin Kaffenberger; Todd Hostetler; Matthew J Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 2.  Systemic therapy of atopic dermatitis in children.

Authors:  Giampaolo Ricci; Arianna Dondi; Annalisa Patrizi; Massimo Masi
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children.

Authors:  Hsiewe Ying Tan; Anthony L Zhang; Charlie C Xue; Dacan Chen; Cliff Da Costa; George B Lenon
Journal:  BMJ Open       Date:  2013-12-30       Impact factor: 2.692

4.  Childhood atopic dermatitis: current developments, treatment approaches, and future expectations

Authors:  Pınar Gür Çetinkaya; Ümit Murat Şahiner
Journal:  Turk J Med Sci       Date:  2019-08-08       Impact factor: 0.973

5.  Does Probiotic Consumption Enhance Wound Healing? A Systematic Review.

Authors:  Camille Togo; Ana Paula Zidorio; Vivian Gonçalves; Patrícia Botelho; Kenia de Carvalho; Eliane Dutra
Journal:  Nutrients       Date:  2021-12-27       Impact factor: 5.717

6.  Antibacterial and Toxicity Evaluation of Eastern Medicine Formulation Eczegone for the Management of Eczema.

Authors:  Muhammad Amjad Chishti; Ejaz Mohi-Ud-Din; Shahbaz Ahmad Zakki; Muhammad Rahil Aslam; Sheraz Siddiqui; Saeed Ahmad; Abdul Hayee
Journal:  Dose Response       Date:  2020-09-04       Impact factor: 2.658

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.